Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
Author(s) -
Robbert J. de Winter,
Fons Windhausen,
Jan H. Cornel,
Peter H.J.M. Dunselman,
C Janus,
Peter E.F. Bendermacher,
H. R. Michels,
Gerard T. Sanders,
Jan G.P. Tijssen,
Freek W.A. Verheugt
Publication year - 2005
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa044259
Subject(s) - medicine , myocardial infarction , cardiology , randomized controlled trial , acute coronary syndrome , troponin
Current guidelines recommend an early invasive strategy for patients who have acute coronary syndromes without ST-segment elevation and with an elevated cardiac troponin T level. However, randomized trials have not shown an overall reduction in mortality, and the reduction in the rate of myocardial infarction in previous trials has varied depending on the definition of myocardial infarction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom